School of Medicine
Showing 61-80 of 83 Results
-
Yushen Qian, MD
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
BioDr. Qian is a board-certified radiation oncologist and a clinical assistant professor in the Stanford University School of Medicine, Department of Radiation Oncology.
In his clinical practice, he specializes in urologic, head and neck, and thoracic cancers, but treats a broad spectrum of cancers including lymphoma, gastrointestinal, and brain tumors. For each patient, he develops a comprehensive, compassionate care plan customized to individual needs. His goal is to deliver the most effective cancer treatment to help patients enjoy the best possible health and quality of life.
In addition to his clinical practice, Dr. Qian has conducted extensive research that is often focused on the impact of radiation therapy on patient outcomes and health care system costs.
He has presented the findings at annual meetings of the American Radium Society, American Society for Radiation Oncology, American Society of Clinical Oncology Cancer Survivorship Symposium, Palliative Care in Oncology Symposium, and elsewhere.
Dr. Qian has published articles in journals such as Clinical Cancer Research, the Journal of Clinical Oncology, Practical Radiation Oncology, the International Journal of Radiation Oncology • Biology • Physics (IJROBP), and more.
Dr. Qian co-authored the chapter on radiation therapy for liver tumors in the book Radiation Therapy for Hepatocellular Carcinoma: Clinical Data. He also co-authored the chapter on liver care for the book Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy.
He has earned numerous honors, including the Malcolm A. Bagshaw Award for leadership and outstanding scientific achievement. -
Elham Rahimy, MD
Clinical Assistant Professor, Radiation Oncology - Radiation Therapy
BioDr. Rahimy is a radiation oncologist who treats patients with brain, spine, and gastrointestinal tumors. She received her medical training at Yale, followed by a residency in radiation oncology at Stanford. She is a clinical assistant professor with the Stanford School of Medicine Department of Radiation Oncology.
Dr. Rahimy specializes in treating several types of cancer, including brain tumors, such as glioma and glioblastoma, spine tumors, metastatic disease, and gastrointestinal cancer, such as rectal cancer and pancreatic cancer. She is credentialed for CyberKnife Radiosurgery. She is also actively involved in radiation oncology research and clinical trials. Her interests include improving patient and resident education and enhancing patient quality of life and survivorship. Dr. Rahimy’s research has been published in a variety of journals. She is also the current radiation oncology medical student clerkship director. -
Jason Barzel Ross
Instructor, Radiation Oncology - Radiation Therapy
BioDr. Ross is a Kaplan Research Fellow in the Department of Radiation Oncology at Stanford University. He completed his undergraduate at Stanford University, where he majored in biological sciences and conducted research in stem cell biology. He then entered the Tri-Institutional MD-PhD Program in New York City, where he obtained his MD from Weill Cornell Medical College and his PhD from Rockefeller University, where he studied breast cancer metastasis. His current research on the influence of radiotherapy on the tumor-immune micro-enrivonment is co-advised by Dr. Irving Weissman and Dr. Maximilian Diehn at Stanford University.
-
Scott G. Soltys, MD
Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery
On Leave from 06/03/2024 To 08/16/2024Current Research and Scholarly InterestsMy clinical and research interests focus on the development of new radiation techniques involving stereotactic radiosurgery and radiotherapy for the treatment of malignant and benign tumors of the brain and spine, as well as functional disorders such as trigeminal neuralgia.
-
Kekoa Taparra, MD, PhD
Resident in Radiation Oncology - Radiation Therapy
BioAloha, my name is Kekoa and I am an Indigenous Native Hawaiian born and raised in Mililani, Oʻahu, Hawaiʻi. My life's mission is to return home to the islands and provide high-quality cancer care to the communities that raised me. I earned my PhD from Johns Hopkins School of Medicine (Cellular and Molecular Medicine) and my MD from Mayo Clinic Alix School of Medicine (Science of Healthcare Delivery Certification), experiences that have prepared me for my current role as a resident physician and postdoctoral medical fellow in the Department of Radiation Oncology at Stanford Health Care. I am a Masters of Public Health Merit Award scholar at Hawaiʻi Pacific University. I'm proud to be a member of the inaugural cohort of the President Barack Obama Foundation Leaders USA program. I also run a lab with over 20 talented Native Hawaiian and other Pacific Islander (NHPI) and NHPI-ally scholars across the nation, focusing on unmasking NHPI health disparities that have been overlooked for decades.
My lab specifically focuses on Pacific Islander health disparities, overcoming Indigenous Erasure, resolving structural racism in NHPI data, and sustainable climate-resilient healthcare systems. We use perspectives from the lived experiences of our communities to help guide the most pertinent research questions. For my research, I have been awarded the inaugural 2023 ASCO Dr. Judith and Alan Kaur Endowed Young Investigator Award along with awards from ASH, ASTRO, NMF, and AACR. My work has been published in The Lancet, NEJM, JAMA, JAMA Oncology, JAMA Internal Medicine, JAMA Health Forum, JNCI, and JCO Oncology Practice, among others. I was selected as a 2022-2023 American Society of Clinical Oncology Journals Editorial Fellow and a 2023-2024 Stanford Cancer Institute Fellow.
As an advocate for Pacific Islander health equity, I strive to engage with community partners, federal agencies, and academic research institutions to educate others on the unique health concerns of our population. I've been invited to speak on NHPI health at institutions such as Harvard, MDACC Grand Rounds, UCLA, UCSF, NIH/NCI, FDA, and Papa Ola Lōkahi, among others. I warmly welcome interdisciplinary collaborations that aim to improve the health of our underserved Pacific Islander communities. -
Nicholas Trakul, MD, PhD
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
BioDr. Nicholas Trakul is a radiation oncologist with Stanford Medicine Cancer Center and clinical associate professor of Radiation Oncology-Radiation Therapy with Stanford School of Medicine. Dr. Trakul serves as Medical Director for Stanford Medicine Radiation Oncology in Pleasanton and for the Stanford Medicine I Sutter Health Cancer Collaborative in Castro Valley.
Dr. Trakul completed residency training at Stanford in 2013 and then joined the faculty at the University of Southern California, where he specialized in head and neck and central nervous system malignancies, with an emphasis on stereotactic radiosurgery (SRS) and stereotactic ablative radiotherapy (SABR/SBRT). He is widely published as first author in peer-reviewed journals. His research focus involves the creation of novel clinical databases as well as outcomes in the treatment of head and neck, gastrointestinal and thoracic malignancies. In 2017, Dr. Trakul returned to Stanford Medicine, becoming the Medical Director of Stanford Medicine Radiation Oncology in Pleasanton. In 2020, he was named Medical Director of Stanford Radiation Oncology Network Sites. In February 2022, Dr. Trakul assumed the medical directorship of Eden Radiation Oncology Center, the first site to become operation under the Stanford/Sutter Cancer Collaborative. He is focused on providing access to high quality radiation therapy, collaboration with community health care systems and creating/maintaining productive and high engagement workplace culture. He believes in providing personalized, high-quality care, and bringing new technology to the East Bay, allowing patients to access cancer care while staying connected to their communities and support networks. -
Lucas Kas Vitzthum, MD
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
BioDr. Vitzthum is a radiation oncologist and clinical associate professor of radiation oncology at Stanford University School of Medicine. He specializes in the treatment of gastrointestinal and thoracic cancers. He also has a clinical and research interest in oligometastatic cancer, which is cancer that has metastasized to a limited number of sites beyond its origin.
He began his career in biomedical engineering and is passionate about integrating new technologies to advance patient care.
Dr. Vitzthum delivers treatment personalized to each patient’s condition, overall health, and goals. He believes clear communication between doctor and patient is vital to help patients make informed care decisions.
His research interests include clinical trial development, survivorship, and predictive modeling to personalize patient treatment. He is especially interested in pursuing research that can address unmet clinical needs.
Dr. Vitzthum has received research support through the Radiological Society of North America, the American Society of Clinical Oncology’s Conquer Cancer Foundation, and the UCSD Altman Clinical and Translational Research Institute. His work has appeared in International Journal of Radiation Oncology Biology Physics, Annals of Oncology, JAMA Oncology, Clinical Cancer Research, and other publications.
He is a member of the American College of Radiation Oncology, American Society for Radiation Oncology, American Society of Clinical Oncology, and Radiologic Society of North America.
Dr. Vitzthum is also interested in improving access to high-quality cancer care for under-served populations domestically and abroad. -
Ziwei Wang
Postdoctoral Scholar, Radiation Therapy
Current Research and Scholarly InterestsMy current work focuses on establishing preclinical platforms to rapidly validate the functional impact of genetic alterations in tumors using both cell and genetically engineered mouse models. We hope this system can accelerate the discovery and translation of novel cancer therapies to patients.
